Fisher MD - Search Results

1

Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world.

Kruse M, Smyth EN, Bowman L, Gautam S, Guimaraes CM, Nisbett AR, Fisher MD, Cui ZL, Sheffield KM, Kalinsky K. Kruse M, et al. Among authors: fisher md. Breast Cancer Res Treat. 2023 Aug;201(1):105-115. doi: 10.1007/s10549-023-06993-1. Epub 2023 Jun 13. Breast Cancer Res Treat. 2023. PMID: 37310540

2

Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.

Vidal GA, Gautam S, Vlahiotis A, Fisher MD, Pulgar S, DeBusk K. Vidal GA, et al. Among authors: fisher md. Future Oncol. 2022 Mar;18(7):849-858. doi: 10.2217/fon-2021-0405. Epub 2021 Nov 10. Future Oncol. 2022. PMID: 34756117

3

Real-world patterns on tumor mutation burden testing in a pan-tumor population.

Gautam S, Kachroo S, DeClue RW, Fisher MD, Basu A. Gautam S, et al. Among authors: fisher md. Future Oncol. 2021 May;17(15):1879-1887. doi: 10.2217/fon-2020-1005. Epub 2021 Jan 29. Future Oncol. 2021. PMID: 33512239

4

Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population.

Gautam S, Kachroo S, DeClue RW, Fisher MD, Basu A. Gautam S, et al. Among authors: fisher md. J Comp Eff Res. 2021 Jul;10(10):857-868. doi: 10.2217/cer-2020-0288. Epub 2021 May 28. J Comp Eff Res. 2021. PMID: 34047199 Free article.

5

Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology Clinics.

DeClue RW, Szamreta EA, Gautam S, Fisher MD, Monberg MJ. DeClue RW, et al. Among authors: fisher md. Future Oncol. 2023 May;19(16):1113-1124. doi: 10.2217/fon-2022-0955. Epub 2023 May 12. Future Oncol. 2023. PMID: 37170823

6

Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapy.

W DeClue R, Fisher MD, Gooden K, Walker MS, Le TK. W DeClue R, et al. Among authors: fisher md. Future Oncol. 2023 Apr;19(13):909-923. doi: 10.2217/fon-2022-0894. Epub 2023 May 16. Future Oncol. 2023. PMID: 37191097 Free article.

7

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015.

Fisher MD, Shenolikar R, Miller PJ, Fenton M, Walker MS. Fisher MD, et al. Clin Genitourin Cancer. 2018 Dec;16(6):e1171-e1179. doi: 10.1016/j.clgc.2018.07.025. Epub 2018 Aug 11. Clin Genitourin Cancer. 2018. PMID: 30206026 Free article.

8

Treatment patterns and clinical outcomes of palbociclib-based therapy received in US community oncology practices.

Lin J, McRoy L, Fisher MD, Hu N, Davis C, Mitra D, Walker MS. Lin J, et al. Among authors: fisher md. Future Oncol. 2021 Mar;17(9):1001-1011. doi: 10.2217/fon-2020-0744. Epub 2020 Nov 10. Future Oncol. 2021. PMID: 33167685 Free article.

9

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.

Fisher MD, Pulgar S, Kulke MH, Mirakhur B, Miller PJ, Walker MS, Schwartzberg LS. Fisher MD, et al. J Gastrointest Cancer. 2019 Dec;50(4):816-823. doi: 10.1007/s12029-018-0160-x. J Gastrointest Cancer. 2019. PMID: 30121904 Free PMC article.

10

Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.

Fisher MD, Fernandes AW, Olufade TO, Miller PJ, Walker MS, Fenton M. Fisher MD, et al. Clin Ther. 2018 Sep;40(9):1522-1537. doi: 10.1016/j.clinthera.2018.07.016. Epub 2018 Aug 25. Clin Ther. 2018. PMID: 30150077 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters